Overview

ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
Patients with a new diagnosis or recurrence of high-grade squamous precancerous lesions or initially non-invasive vulvar Paget's disease, who have not undergone other types of treatment, will be considered at the Fondazione Policlinico Universitario A. Gemelli - IRCCS - in Rome.
Phase:
PHASE2
Details
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Treatments:
Bleomycin
Cisplatin